Evidence map›Paper›PMID 29155898›Full record

ArticlePloS one2017

Protective effect of Malva sylvestris L. extract in ischemia-reperfusion induced acute kidney and remote liver injury.

Houshang Najafi, Zeynab Mohamadi Yarijani, Saeed Changizi-Ashtiyani, Kamran Mansouri, Masoud Modarresi, Seyed Hamid Madani, Bahar Bastani

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Nephroprotective and Antioxidant Effects ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Protective Effects of the Aqueous Extract ofCurrent pharmaceutical design · 2024
    Article
  7. Article
  8. Kidney injury in COVID-19 patients, drug development and their renal complications: Review study.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  9. Article
  10. A Review on Health Benefits ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Houshang NajafiMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Zeynab Mohamadi YarijaniMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Saeed Changizi-AshtiyaniDepartment of Physiology, School of Paramedical Sciences, Arak University of Medical Sciences, Arak, Iran.
Kamran MansouriMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Masoud ModarresiPharmacognosy and Biotechnology Department, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Seyed Hamid MadaniDepartment of Pathology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Bahar BastaniDivision of Nephrology, School of Medicine, Saint Louis University, Saint Louis, Missouri, United States of America.ORCID http://orcid.org/0000-0002-2138-4248
Kermanshah University of Medical Sciences · IRArak University of Medical Sciences · IRSaint Louis University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mallow (Malva sylvestris L.) has had medicinal and therapeutic uses in addition to its oral consumption. The present study was conducted to examine the protective effect of Malva sylvestris L. extract on ischemia-reperfusion-induced kidney injury and remote organ injuries in the liver. Before ischemia-reperfusion, rats in the different groups received intraperitoneal normal saline or mallow extract at the doses of 200, 400 or 600 mg/kg of body weight. After 30-minutes of bilateral renal ischemia followed by 24-hours of reperfusion, tissue damage in the kidney and liver samples were determined through studying H&E-stained slides under a light microscope. The degree of leukocyte infiltration and tissue mRNA expressions of TNF- and ICAM-1 were then measured to examine the degree of renal inflammation. The renal tissue MDA and FRAP levels were measured for determining the amount of oxidative stress. Plasma concentrations of creatinine, urea, ALT and ALP were also measured. Ischemia-reperfusion led to a significant increase in plasma concentrations of creatinine, urea, ALT and ALP, and renal tissue MDA, and a significant decrease in renal tissue FRAP. The expression of pro-inflammatory factors in the kidney tissue, the level of leukocyte infiltration and the amount of tissue damage in the kidney and liver also increased. Pretreatment by mallow extract led to a significant improvement in all the variables measured. The 200- and 400-mg doses yielded better results in most parameters compared to the 600-mg dose. The findings showed that mallow extract protects the kidney against ischemia-reperfusion and reduces remote organ injury in the liver.

Indexed as

Alanine TransaminaseAlkaline PhosphataseAnimalsCreatinineDose-Response Relationship, DrugGene Expression RegulationIntercellular Adhesion Molecule-1KidneyLiverMaleMalondialdehydeMalvaNeutrophil InfiltrationOxidative StressPlant ExtractsProtective AgentsAlanine TransaminaseAlkaline PhosphataseCreatinineIntercellular Adhesion Molecule-1MalondialdehydemTOR protein, ratPlant ExtractsProtective AgentsTOR Serine-Threonine KinasesTumor Necrosis Factor-alphaUrea

Identifiers

PMID29155898
PMCPMC5695808
OpenAlexW2769963521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.